MedPath

Arginine effect on height growth of childre

Phase 1
Recruiting
Conditions
Short stature.
Short stature (child)
R62.52
Registration Number
IRCT20230603058376N1
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
76
Inclusion Criteria

Children in pre-pubertal ages
Absence of any underlying diseases
Not below the lower normal height limit
No indications for growth hormone prescription

Exclusion Criteria

Having reached sexual maturity
Presence of underlying diseases such as diabetes, hypothyroidism, or kidney diseases
Height below the lower normal limit
Past or current use of growth hormone
Sensitivity or adverse reactions to Vitamin D or Arginine

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Height of a child. Timepoint: 12 months with 3 month interval. Method of measurement: Height measuring device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath